Solventum Corp 8-K Filing

Ticker: SOLV · Form: 8-K · Filed: Sep 26, 2024 · CIK: 1964738

Solventum Corp 8-K Filing Summary
FieldDetail
CompanySolventum Corp (SOLV)
Form Type8-K
Filed DateSep 26, 2024
Pages2
Reading Time3 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a 8-K filing submitted by Solventum Corp (ticker: SOLV) to the SEC on Sep 26, 2024.

What are the key financial figures in this filing?

Key dollar amounts include: $0.01 (ich registered Common Stock, par value $0.01 per share SOLV New York Stock Exchange).

How long is this filing?

Solventum Corp's 8-K filing is 2 pages with approximately 654 words. Estimated reading time is 3 minutes.

Where can I view the full 8-K filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 654 words · 3 min read · ~2 pages · Grade level 13.8 · Accepted 2024-09-26 17:27:19

Key Financial Figures

  • $0.01 — ich registered Common Stock, par value $0.01 per share SOLV New York Stock Exchange

Filing Documents

03

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 20, 2024, the Board of Directors (the "Board") of Solventum Corporation ("Solventum") approved amended and restated Bylaws of Solventum (the "Bylaws"), which were effective as of such date. The Bylaws include the following amendments: Article II, Sections 2.9 and 2.11 of the Bylaws have been amended to update the advance notice and related procedural and disclosure requirements by which a stockholder may propose business in connection with an annual meeting of stockholders, including (i) eliminating the requirements that a nominating stockholder provide information with respect to "any principal competitor" of Solventum and the background of any other person or entity on whose behalf a nomination is being made, and (ii) clarifying that the type of "support" of other stockholders to be disclosed is financial support. Article II, Section 2.12 of the Bylaws has been amended to remove subsection (D), which required that nominees to the Board tender irrevocable resignations that would become effective upon certain determinations by the Board. Article VI, Section 6.1 of the Bylaws has been amended to include Solventum directors, officers, and employees as eligible for indemnification, which aligns the Bylaws with the indemnification provision of Solventum's Amended and Restated Certificate of Incorporation. In addition, the Board approved certain other administrative changes, including technical and conforming revisions and clarifications. The description set forth under this Item 5.03 does not purport to be complete and is qualified in its entirety by reference to the full text of the Bylaws, as amended and restated on September 20, 2024, which are attached hereto as Exhibit 3.1 and incorporated herein by reference.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 3.1 Amended and Restated Bylaws of Solventum Corporation, as adopted September 20, 2024

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 26, 2024 SOLVENTUM CORPORATION By: /s/ Matthew Rice Matthew Rice Vice President, Associate General Counsel & Assistant Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.